Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial-Reference-Cited by-同舟云学术

Intravenous Amantadine for Freezing of Gait Resistant to Dopaminergic Therapy: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Clinical Trial

Published:2012-11-19 Issue:11 Volume:7 Page:e48890
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kim Young Eun,Yun Ji Young,Yang Hui June,Kim Han-Joon,Gu Namyi,Yoon Seo Hyun,Cho Joo-Youn,Jeon Beom S.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Freezing phenomenon in patients with parkinsonian syndromes;N Giladi;Mov Disord,1997

2. Motor blocks in Parkinson's disease;N Giladi;Neurology,1992

3. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait;O Moore;Mov Disord,2007

4. Freezing of gait and activity limitations in people with Parkinson's disease;DM Tan;Arch Phys Med Rehabil,2011

5. A pathophysiological model of freezing of gait in Parkinson's disease;SJ Lewis;Parkinsonism Relat Disord,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson’s Disease;Neuropsychiatric Disease and Treatment;2021-09

2. Freezing of Gait in Parkinson’s Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms;Parkinson's Disease;2021-01-12

3. Non-Dopaminergic Treatments for Motor Control in Parkinson’s Disease: An Update;CNS Drugs;2020-08-12

4. Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments;Translational Neurodegeneration;2020-04-15

5. Amantadine and memantine: a comprehensive review for acquired brain injury;Brain Injury;2020-02-20